Holly Hagan

Scroll

Professor Emeritus

Dr. Holly Hagan is Professor Emeritus at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders. Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.

Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY.

Education

PhD Epidemiology, University of Washington, Seattle, WA

MPH Epidemiology, University of Massachusetts, Amherst, MA

BA Russian Studies, Evergreen State College, Olympia, WA

Publications

Time Since Migration and HIV Risk Behaviors Among Puerto Ricans Who Inject Drugs in New York City

Trends in condom use among MSM in the United States : The role of antiretroviral therapy and seroadaptive strategies

Binge drinking and risky sexual behavior among HIV-negative and unknown HIV status men who have sex with men, 20 US cities

Early linkage to HIV care and antiretroviral treatment among men who have sex with men-20 Cities, United States, 2008 and 2011

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013 : A systematic analysis for the Global Burden of Disease Study 2013

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013 : A systematic analysis for the Global Burden of Disease Study 2013

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013 : Quantifying the epidemiological transition

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013 : A systematic analysis for the Global Burden of Disease Study 2013

Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID) : A systematic review and meta-analysis

HIV infection among people who inject drugs in the United States : Geographically explained variance across racial and ethnic groups

Hybrid STTR intervention for heterosexuals using anonymous HIV testing and confidential linkage to care : A single arm exploratory trial using respondent-driven sampling

Illicit drug use and HIV risk in the Dominican Republic : Tourism areas create drug use opportunities

Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men

Perceptions of genetic testing and genomic medicine among drug users

Strategies to uncover undiagnosed HIV infection among heterosexuals at high risk and link them to HIV care with high retention : A "seek, test, treat, and retain" study

Will "combined prevention" eliminate racial/ethnic disparities in HIV infection among persons who inject drugs in New York City?

A perfect storm : Crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City

Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries : An international systematic review

Combined HIV prevention, the New York City Condom Distribution Program, and the evolution of safer sex behavior among persons who inject drugs in New York City

Correlates of selling sex among male injection drug users in New York City

Factors associated with recent HIV testing among men who have sex with men in New York City

Hepatitis C virus infection among HIV-positive men who have sex with men : Protocol for a systematic review and meta-analysis

HIV infection and risk, prevention, and testing behaviors among injecting drug users - National HIV behavioral surveillance system, 20 U.S. Cities, 2009

HIV risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection - National HIV behavioral surveillance system, 21 U.S. cities, 2010